Identifying functional and anatomic mechanisms of glucose mobilization by cholecystokinin b receptor containing neurons in the ventromedial nucleus of the hypothalamus
Project Number5K08DK129722-03
Former Number1K08DK129722-01
Contact PI/Project LeaderAFFINATI, ALISON HOLLEY
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
Abstract
Nutrient mobilization fuels the metabolic activity needed to fight or escape threats and is a critical
component of the central nervous system (CNS) response to stress. While mild stress-induced hyperglycemia
is associated with improved survival in critical illness, severe or chronic responses are associated with
development of diabetes. The sympathetic nervous system (SNS) plays a crucial role in coordinating the
response to stress; however, the specific mechanisms and neural circuits by which the brain mediates SNS-
dependent stress responses, including nutrient mobilization, remain poorly understood. Pre-autonomic neurons
in the ventromedial nucleus of the hypothalamus (VMN) modulate SNS outflow to multiple organs and can
mediate a diverse range of responses, including hepatic glucose production, glucose disposal, and energy
expenditure. We have recently identified a subset of VMN neurons (marked by cholecystokinin b receptor (Cckbr)
expression (VMNCCKBR neurons)) that are activated by stressors (including restraint and noxious stimuli) and
mediate glucose and lipid mobilization as well as defensive freezing behaviors, suggesting that VMNCCKBR cells
coordinate multiple responses to specific stressors. Single nucleus RNA-Sequencing (snRNA-Seq) analysis of
the VMN reveals that VMNCCKBR neurons distribute across multiple transcriptionally defined classes of neurons
within the VMN (VMN T-types) and they project to multiple brain regions, including the preoptic area (POA;
involved in metabolism) and the periaqueductal gray (PAG; implicated in the behavioral response to threats).
The goals of this proposal are to define the anatomic neural circuits and functional mechanisms of
VMNCCKBR neuron-mediated nutrient mobilization and to test the hypothesis that VMNCCKBR neurons
mediate metabolic and behavioral stress responses through independent neural pathways. We will
identify the target tissues of VMNCCKBR neurons using optogenetic-stimulated norepinephrine turnover and will
determine the mechanisms through which VMNCCKBR neurons regulate acute hepatic glucose production using
stable isotope fluxomics. We will then assess whether VMNCCKBR-dependent lipid mobilization contributes to
glucose production chronically. To identify which populations of VMNCCKBR neurons regulate nutrient mobilization
versus defensive behaviors, we will use retrograde tracing followed by snRNA-Seq to define clusters that project
to the POA and PAG respectively. We will then use optogenetic activation of VMNCCKBR neuron terminals
projecting to the POA and PAG to establish the functional outputs of these cell classes. This work will define the
anatomic and functional mechanisms driving SNS-dependent stress-mediated nutrient mobilization. Completion
of this project will provide training in liver and white adipose physiology, neuroanatomical tracing, behavioral
phenotyping and genomic bioinformatics, allowing me to become an expert in central nervous system regulation
of glucose homeostasis and providing the tools necessary to transition to an independent career as a physician-
scientist.
Public Health Relevance Statement
Project Narrative
Stress-induced hyperglycemia is an important survival response that fuels the metabolic activity needed to fight
and escape threats; however severe or chronic activation of this response can lead to diabetes. This project
aims to define the neural circuits and metabolic mechanisms that regulate stress-induced glucose mobilization
and differentiate these from the circuits that mediate stress-induced behaviors. Once these mechanisms have
been identified, we will be able to develop therapeutics that can target metabolic outcomes of stress-induced
hyperglycemia without affecting behavioral responses.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
073133571
UEI
GNJ7BBP73WE9
Project Start Date
01-August-2022
Project End Date
31-July-2027
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$169,560
Direct Costs
$157,000
Indirect Costs
$12,560
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Diabetes and Digestive and Kidney Diseases
$169,560
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K08DK129722-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K08DK129722-03
Patents
No Patents information available for 5K08DK129722-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K08DK129722-03
Clinical Studies
No Clinical Studies information available for 5K08DK129722-03
News and More
Related News Releases
No news release information available for 5K08DK129722-03
History
No Historical information available for 5K08DK129722-03
Similar Projects
No Similar Projects information available for 5K08DK129722-03